Ticker LaunchRegulation A · Tier 2
RespireRx Pharmaceuticals Inc.
RespireRx Pharmaceuticals Inc. filed a Tier 2 Regulation A offering statement (Form 1-A) on Aug 9, 2021 for up to $7.5M at $0.02 per security. The SEC qualified the offering on Dec 13, 2021.
- Status
- Qualified
- Tier
- Tier 2
- Offering size
- $7.5M
- Offer price
- $0.02
- Security type
- Equity (common or preferred stock)
- Filed
- Aug 9, 2021
- Qualified
- Dec 13, 2021
- Industry
- Pharmaceutical Preparations
- State
- NJ
More on this offering for subscribers
- Revenue, net income and total assets from the offering statement
- Employees
- Market cap at the offer price
- Auditor
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Offering statement (Form 1-A) Aug 9, 2021
- Final offering circular (253G2)
- All filings on EDGAR CIK 849636
Other qualified Biotech & pharma Reg A offerings
- Sibannac, Inc.Feb 7, 2022 · $9.4M
- Aibotics, Inc.Jan 18, 2022 · $15M
- Gelstat CorpDec 17, 2021 · $5M
- Coeptis Therapeutics Inc.Dec 3, 2021 · $12M
- Marijuana Co of America, Inc.Oct 20, 2021 · $10M
- Mystic Holdings Inc./NVSep 21, 2021 · $65.4M